Concepedia

Kavita Natrajan

KN

6

Publications

190

Citations

6

H-Index

2012

Active since

Affiliations

Augusta University(Current)

Georgia Regents Medical Center

Emory University

University of Iowa

Medical University of South Carolina

Kavita Natrajan is an author at Augusta University specializing in tumor immunity, cancer therapeutics, and immunology.

ORCID

Top concepts

Publications per year

2012–2024

6

Publications

6

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

Moshe Talpaz, Ronald Paquette, Lawrence B. Afrin et al. · Journal of Hematology & Oncology · 2013 · 94 citations · Full text

FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma

Kavita Natrajan, Megha Kaushal, Bindu George et al. · Clinical Cancer Research · 2024 · 35 citations · Full text

, , +18

Are There True Non-Responders to Hydroxyurea in Sickle Cell Disease? a Multiparameter Analysis

Arati Rani Chand, Hongyan Xu, Leigh Wells et al. · Blood · 2014 · 19 citations

Pomalidomide In Sickle Cell Disease: Phase I Study Of a Novel Anti-Switching Agent

Abdullah Kutlar, Paul Swerdlow, Steffen E. Meiler et al. · Blood · 2013 · 16 citations

Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50–100 × 109/L): A Comparison to Patients with Normal or High Starting Platelet Counts

Moshe Talpaz, Ronald Paquette, Lawrence B. Afrin et al. · Blood · 2012 · 14 citations

Rows per page

1–5 of 6